Cohen, A., Susanibar-Adaniya, S., Garfall, A., Vogl, D., Kapur, S., Waxman, A., Zubka, D., Hwang, W., Diaczynsky, C., Noll, J. H., Ho, M., Paruzzo, L., Yi, B., Xu, R., Thai, E., Gonzalez, V., Michener, P., Ruella, M., Fraietta, J., Stadtmauer, E. (2025). Phase 2 study of cevostamab consolidation following BCMA CAR T cell therapy:  preliminary safety, efficacy, and correlative data from the “STEM” (Sequential T Cell-Engagement for Myeloma) trial. Blood. https://doi.org/10.1182/blood-2025-699